World’s First Really Smart Cannabis Inhaler is Coming to Florida
Metered-dose based vaporizer, works in conjunction with an App to provide adaptive dosing allowing patients to vary their dose based on their current levels of pain.
Liberty Health Sciences Inc. today announced an exclusive partnership with Resolve Digital Health Inc. to have Resolve’s industry-leading smart inhalation products exclusively distributed through Liberty within the state of Florida, subject to approval of the same by the Florida Department of Health, Office of Medical Marijuana Use as is required under Florida law.
Resolve’s smart technology is based on proprietary Artificial Intelligence algorithms that track patient usage data through a mobile application to facilitate sharing with doctors, pharmacists and other caregivers, and allows patients and healthcare professionals to monitor the efficacy of treatment in order to continuously improve their medical cannabis experience.
Our partnership with Resolve further supports our commitment to being industry leaders in the medical cannabis space by offering our patients innovative and safe methods to inhale cannabis. The Aphria brand is dedicated to patient well-being which makes the Resolve inhaler a perfect addition to our product portfolio. We’re very pleased to be partnering with Resolve to bring their state-of-art technology, and a heightened understanding of patients’ needs to the Florida market.
Breeze Smart Inhalers, their metered-dose based vaporizer, works in conjunction with the Breeze App to provide a patent-pending adaptive dosing function. This allows patients to vary their dose based on their current levels of pain and through machine learning analysis of their activity patterns, time of day, local weather conditions, sleep history and other collected and reported data.